China Pharma Holdings, Inc. (CPHI) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.65. It has a SharesGrow Score of 26/100, indicating a weak investment profile with 0 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of CPHI = $19,073,100.00 (+2938844276% from the current price, the stock appears undervalued).
Valuation: CPHI trades at a trailing Price-to-Earnings (P/E) of -0.8 (S&P 500 average ~25).
Financials: revenue is $4.1T, +30502143.4%/yr average growth. Net income is $3.2T (loss), growing at -22433170.5%/yr. Net profit margin is -76.9% (negative). Gross margin is -3.2% (+2.9 pp trend).
Balance sheet: total debt is $183.2B against $22.7T equity (Debt-to-Equity (D/E) ratio 0.01, conservative). Current ratio is 0.32 (tight liquidity). Debt-to-assets is 0.6%. Total assets: $31.0T.
SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 33/100 (Fail), Moat 35/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).
